IL145761A0 - Il-8 receptor antagonists - Google Patents

Il-8 receptor antagonists

Info

Publication number
IL145761A0
IL145761A0 IL14576100A IL14576100A IL145761A0 IL 145761 A0 IL145761 A0 IL 145761A0 IL 14576100 A IL14576100 A IL 14576100A IL 14576100 A IL14576100 A IL 14576100A IL 145761 A0 IL145761 A0 IL 145761A0
Authority
IL
Israel
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Application number
IL14576100A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL145761A0 publication Critical patent/IL145761A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL14576100A 1999-06-16 2000-06-15 Il-8 receptor antagonists IL145761A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13967599P 1999-06-16 1999-06-16
PCT/US2000/016499 WO2000076495A1 (en) 1999-06-16 2000-06-15 Il-8 receptor antagonists

Publications (1)

Publication Number Publication Date
IL145761A0 true IL145761A0 (en) 2002-07-25

Family

ID=22487790

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14576100A IL145761A0 (en) 1999-06-16 2000-06-15 Il-8 receptor antagonists

Country Status (20)

Country Link
EP (1) EP1185261A4 (en)
JP (1) JP2003501459A (en)
KR (1) KR20020010709A (en)
CN (1) CN1355697A (en)
AR (1) AR030391A1 (en)
AU (1) AU766083B2 (en)
BR (1) BR0010802A (en)
CA (1) CA2377341A1 (en)
CO (1) CO5200760A1 (en)
CZ (1) CZ20014471A3 (en)
HK (1) HK1044483A1 (en)
HU (1) HUP0201571A3 (en)
IL (1) IL145761A0 (en)
MX (1) MXPA01013004A (en)
NO (1) NO20016053D0 (en)
NZ (1) NZ514695A (en)
PL (1) PL352232A1 (en)
TR (1) TR200103680T2 (en)
WO (1) WO2000076495A1 (en)
ZA (1) ZA200109479B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521479B2 (en) * 2001-04-16 2009-04-21 Panacea Pharmaceuticals, Inc. Methods of treating prion disease in mammals
GB0201882D0 (en) * 2002-01-28 2002-03-13 Novartis Ag Organic compounds
KR20050026091A (en) * 2002-08-01 2005-03-14 뉴로서치 에이/에스 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
US7550499B2 (en) 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
WO2005113534A2 (en) * 2004-05-12 2005-12-01 Schering Corporation Cxcr1 and cxcr2 chemokine antagonists
TW200600492A (en) 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
CA2580690A1 (en) 2004-10-21 2006-05-04 Transtech Pharma, Inc. Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
ATE499370T1 (en) 2005-01-19 2011-03-15 Bristol Myers Squibb Co 2-PHENOXY-N-(1,3,4-THIADIZOL-2-YL)PYRIDINE-3-AMINE DERIVATIVES AND RELATED COMPOUNDS AS P2Y1 RECEPTOR INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES
WO2006089871A2 (en) * 2005-02-23 2006-08-31 Neurosearch A/S Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
EP1896466B1 (en) 2005-06-27 2011-04-13 Bristol-Myers Squibb Company N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
EP1896417B1 (en) 2005-06-27 2011-03-23 Bristol-Myers Squibb Company Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
US7700620B2 (en) 2005-06-27 2010-04-20 Bristol-Myers Squibb Company C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7714002B2 (en) 2005-06-27 2010-05-11 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
JP2008184403A (en) * 2007-01-29 2008-08-14 Japan Health Science Foundation New hepatitis c virus inhibitor
KR100982661B1 (en) * 2008-04-22 2010-09-17 전남대학교산학협력단 Pharmaceutical composition for the prevention and treatment of malaria containing a compound that inhibits plasmincin II activity as an active ingredient and a method for treating malaria using the same
KR100970940B1 (en) * 2010-05-03 2010-07-20 전남대학교산학협력단 Pharmaceutical composition for preventing and treating malaria comprising compounds that inhibit Plasmepsin II activity and the method of treating malaria using thereof
US10093617B1 (en) * 2015-10-30 2018-10-09 Sumitomo Chemical Company, Limited Method for producing 2-amino-4-substituted phenol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 receptor antagonists
AU6035899A (en) * 1998-09-18 2000-04-10 Smithkline Beecham Corporation Cxcr2 inhibitors and pmn adhesion and t-cell chemotaxis

Also Published As

Publication number Publication date
PL352232A1 (en) 2003-08-11
TR200103680T2 (en) 2002-07-22
MXPA01013004A (en) 2002-07-30
BR0010802A (en) 2002-02-19
HUP0201571A2 (en) 2002-08-28
CA2377341A1 (en) 2000-12-21
CZ20014471A3 (en) 2002-08-14
AR030391A1 (en) 2003-08-20
HK1044483A1 (en) 2002-10-25
ZA200109479B (en) 2002-11-18
NZ514695A (en) 2004-05-28
CN1355697A (en) 2002-06-26
JP2003501459A (en) 2003-01-14
NO20016053L (en) 2001-12-11
EP1185261A4 (en) 2004-02-25
CO5200760A1 (en) 2002-09-27
EP1185261A1 (en) 2002-03-13
NO20016053D0 (en) 2001-12-11
AU766083B2 (en) 2003-10-09
WO2000076495A1 (en) 2000-12-21
AU5741300A (en) 2001-01-02
KR20020010709A (en) 2002-02-04
HUP0201571A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
IL145761A0 (en) Il-8 receptor antagonists
DZ3309A1 (en) Il-8 receptor antagonists
AU4560601A (en) Il-8 receptor antagonists
IL145762A0 (en) Il-8 receptor antagonists
IL146046A0 (en) Il-8 receptor antagonists
AP2002002599A0 (en) Il-8 receptor antagonists
PL351947A1 (en) Il-8 receptor antagonists
EP1047424A4 (en) Il-8 receptor antagonists
EP1039903A4 (en) Il-8 receptor antagonists
EP1194143A4 (en) Il-8 receptor antagonists
EP1261329A4 (en) Il-8 receptor antagonists
HK1044475A1 (en) Il-8 receptor antagonists
HUP0202019A3 (en) Il-8 receptor antagonists
HUP0202004A3 (en) Il-8 receptor antagonists
IL140983A0 (en) Il-8 receptor antagonists
EP1237548A4 (en) Il-8 receptor antagonists
ZA985975B (en) IL-8 receptor antagonists
ZA985813B (en) IL-8 receptor antagonists
EP1087661A4 (en) Il-8 receptor antagonists
EP1121360A4 (en) Il-8 receptor antagonists